Tag: USFDA news
US FDA approves Sohonos for FOP fibrodysplasia ossificans progressiva
FOP is a very rare genetic connective tissue disorder characterized by the abnormal development of bone in areas…
DCGI launches an investigation into antipsychotic drugs made without authorization.
In its most recent meeting, the National Pharmaceutical Pricing Authority (NPPA) set a ceiling price for the antipsychotic…
Sequana Medical’s IND application to begin the phase 1/2a MOJAVE study with DSR 2.0 to treat congestive heart failure has been approved by the US FDA.
The US Food and Drug Administration (FDA) has approved Sequana Medical NV’s investigational new drug (IND) application for…
New US FDA certifications for Abbott’s life support system will enable medical professionals to treat more seriously ill patients.
The US Food and Drug Administration (FDA) recently granted Abbott two more clearances for the company’s market-leading life…
The UK MHRA has approved the chemotherapeutic medication Cisplatin from Venus Remedies for marketing.
Cisplatin, a chemotherapy drug used as a first-line treatment for advanced ovarian cancer, testicular cancer, and bladder carcinoma,…
To evaluate the PEF rate of lung function in asthma patients, Tenovi develops a cellular remote Peak Flow Metre that has been approved by the US FDA.
Tenovi offers Tenovi, a leader in US FDA-approved remote patient monitoring (RPM) solutions, recently announced the release of…
In persons with certain forms of adjuvant liver cancer, Roche reports that the Tecentriq + Avastin phase III IMbrave050 research lowers the likelihood of the cancer coming back.
Avastin (bevacizumab) plus Tecentriq (atezolizumab) showed a statistically significant improvement in recurrence-free survival (RFS) in patients with hepatocellular…
